With 3 Buy ratings and 1 Hold, the word on the Street is that TCMD is a Strong Buy. Dried flower sales in Germany grew 181% in Q1 2021 over Q1 2020 due to increased supply and patient demand. Company has strong performance despite unprecedented volatility. After gold slipped on Monday, ETFs saw their largest inflows in at least a year as investors bought the dip. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships. Aptiv has a leading position in all three. 28 Indica. (See MTCH stock analysis on TipRanks)MGE Energy (MGEE)On the surface, the last stock on our list would seem to be a good buy. In the meantime, we are focused on further optimizing our operating footprint through a full end-to-end strategy that looks at people, process, technology, and infrastructure that we believe will lead to best in class margins over time.". Issued – 370,865,639 shares and 350,112,927 shares, respectively, Total Canopy Growth Corporation shareholders’ equity, Total liabilities and shareholders’ equity, CONDENSED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS, Selling, general and administrative expenses, Net loss attributable to noncontrolling interests and The stock is currently selling for $84.51, and the average price target, at $100, suggests it has an 18% upside potential. The sites have a global reach, with 9.3 million subscribers; of that number, more than 4.5 million are in North America.So far, 2020 has been good for Match Group; EPS for the second quarter hit 51 cents, beating the forecast by 4%, and the company’s shares are up 50%.Morgan Stanley’s Lauren Cassel sees plenty of potential in Match Group – especially in the company’s smaller brand, Hinge. The Green Fund is Asia Pacific's preeminent media house, positioned at the forefront of the global cannabis industry. Recreational B2B net sales declined by 10% from Q1 2020 primarily as a result of increased competition driving lower market share in dried flower, partially offset by new cannabis 2.0 products and reduced provisions for returns. Only Buy ratings, 4, in fact, have been issued in the last three months. And the bank’s analysts have found the stocks that investors should and should not buy into. However, reduced production capacity of the company due to the closure of two greenhouses in British Columbia, an indoor facility in Saskatchewan and a hemp farming operation in New York is likely to show on the company’s fiscal first-quarter results. The year-over-year increase due primarily to the prior year quarter being impacted by the transition of medical customers to the Spectrum Therapeutics online store and limited supply of medical cannabis medical products, as well as higher average basket size we saw in Q1 2021. Any recommendations or opinions stated in a report are done so based on assumptions made by The Green Fund. With shares changing hands for $8.11, several members of the Street recommend pulling the trigger before it heats up.Piper Sandler analyst Steven Mah points out that even against the backdrop of COVID-19, PROG managed to deliver with its Q2 2020 performance. However, a second day of price declines didn’t spark the same appetite, with some selling of bullion-backed funds, according to preliminary data compiled by Bloomberg.“ETFs increased in recent days and now they pause to see what will happen,” said Georgette Boele, a precious metals strategist at ABN Amro Bank NV. Launched shopcanopy.com (“ShopCanopy”) ecommerce site in current quarter; ShopCanopy provides a one-stop shopping destination for the Company’s growing portfolio of CBD products in the U.S. BioSteel RTD non-CBD beverages in new environmentally friendly Tetrapak packaging is now available for sale online in the U.S; we are actively engaging with major retailers in an effort to expand distribution of BioSteel products to key markets across the U.S. Since peaking in early September, the main indexes have lost between 5% and 10% in the last three weeks, in a series of roller coaster trading sessions. All financial information in this press release is reported in millions of Canadian dollars, unless otherwise indicated. With the global economic recovery stuttering as the virus flares, inflation is unlikely to be uppermost in the minds of investors, according to Ole Hansen, head of commodity strategy at Saxo Bank A/S.Key MilestonesGold’s decline this week gathered momentum after it slipped below its 50-day moving average, which technical traders can take as a signal to sell. 2 Cannabis 2.0 products include cannabis-infused chocolates, cannabis-infused beverages, and cannabis vape products (including power sources such as rechargeable and compact batteries, ready-to-go vape pens, and cartridges/vape pods). The company missed estimates in two of the trailing four quarters and surpassed estimates in the other two, the average negative surprise being 111.17%. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. S&B vaporizer revenue in Q1 2021 increased 74% over Q1 2020, benefiting from expanded distribution in, This Works sales in Q1 2021 increased 160% over Q1 2020 due in part to the recognition of a full quarter of revenue in Q1 2021 (compared to less than a month of revenue in Q1 2020 following the acquisition of This Works by the Company in. ", We grew our revenue year-over-year and are seeing market share improvement, notably achieving number one market share in cannabis-infused beverages in the Canadian market.David Klein, CEO, "Following our previously announced restructuring actions, we have substantially reduced our expense and cash burn in this quarter in addition to reducing headcount by over 18% since beginning of this calendar year.